YX-2-107 is a PROTAC that selectively targets and degrades CDK6. Its structural design enables effective inhibition of RB phosphorylation and downregulation of FOXM1 expression. This compound serves as a valuable tool for investigating Ph chromosome-positive acute lymphoblastic leukemia (ALL).
Usually ships within 24 hours.